# ZebiAI Therapeutics, Inc. — Form D

ZebiAI Therapeutics, Inc. of CHESTNUT HILL, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-03. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2020-01-03
- Form: D
- Accession: 0001798584-20-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 6
- Date of first sale: 2019-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-357056

## Issuer

- Name: ZebiAI Therapeutics, Inc.
- CIK: 0001798584
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 40 SINGLETREE ROAD, CHESTNUT HILL, MA, 02467
- Phone: 781-419-6917

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Philip C Austin | Director | Chestnut Hill, MA |
| Brant C Binder | Director | Chestnut Hill, MA |
| Richard C Wagner | Director | Columbus, OH |
| Brant C Binder | Executive Officer | Chestnut Hill, MA |

## More

- [CIK 1798584 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1798584&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001798584-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.